BRIEF published on 06/11/2024 at 18:12, 5 months 11 days ago Funding Circle Plc Executes Share Buyback London Stock Exchange Ordinary Shares Share Buyback Funding Circle Capital Cancellation
PRESS RELEASE published on 06/11/2024 at 18:07, 5 months 11 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase of 250,000 ordinary shares for cancellation at prices between 87.40p and 90.60p as part of buy-back program London Stock Exchange Buy-back Program Share Purchase Cancellation Funding Circle Plc
BRIEF published on 06/10/2024 at 18:03, 5 months 12 days ago Funding Circle Plc: Share Buy-Back Transaction Details Share Buy-back London Stock Exchange Numis Securities Funding Circle Capital Adjustment
PRESS RELEASE published on 06/10/2024 at 17:58, 5 months 12 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 147,312 of its ordinary shares on the London Stock Exchange as part of a buy-back program London Stock Exchange Buy-back Program Own Shares Funding Circle Plc POS-Transaction
BRIEF published on 06/07/2024 at 18:17, 5 months 15 days ago Funding Circle Plc: Share Buy-Back and Cancellation Share Buy-back London Stock Exchange Transparency Rules Capital Reduction Funding Circle
PRESS RELEASE published on 06/07/2024 at 18:12, 5 months 15 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of 199,183 ordinary shares at 90.00p highest price per share as part of a buy-back program Ordinary Shares Buy-back Program Purchase Cancellation Funding Circle Holdings PLC
BRIEF published on 06/06/2024 at 18:03, 5 months 16 days ago Funding Circle Plc: POS-Transaction in Own Shares London Stock Exchange Share Buyback Market Abuse Regulation Numis Securities Funding Circle Holdings
PRESS RELEASE published on 06/06/2024 at 17:58, 5 months 16 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 213,200 ordinary shares on the London Stock Exchange as part of its buy-back program. Details of the transaction included London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRIEF published on 06/05/2024 at 18:01, 5 months 17 days ago Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back London Stock Exchange Ordinary Shares Numis Securities Funding Circle
PRESS RELEASE published on 06/05/2024 at 17:56, 5 months 17 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of 185,223 of its ordinary shares on the London Stock Exchange as part of its buy-back program London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
Published on 11/22/2024 at 23:55, 8 hours 23 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 8 hours 48 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 9 hours 13 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 9 hours 48 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 3 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 14 hours 24 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 15 hours 22 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 16 hours 17 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 1 hour ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 12 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 14 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 14 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
